Thorax

HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH REGISTER
[Advanced]

Thorax. Published Online First: 4 April 2008. doi:10.1136/thx.2007.088930
Copyright © 2008 BMJ Publishing Group Ltd & British Thoracic Society

This Article
Right arrow Full Text (Rapid PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this link to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Add article to my folders
Right arrow Download to citation manager
Google Scholar
Right arrow Articles by Lewis, C. A.
Right arrow Articles by Kolbe, J.
PubMed
Right arrow PubMed Citation
Right arrow Articles by Lewis, C. A.
Right arrow Articles by Kolbe, J.

Papers

Isolated nocturnal desaturation in COPD: prevalence and impact on quality of life and sleep

Christopher Andrew Lewis 1*, Wendy Ferguson 1, Tam Eaton 1, Irene Zeng 1 and John Kolbe 2

1 Auckland City Hospital, New Zealand
2 Auckland City Hospital and University of Auckland, New Zealand

* To whom correspondence should be addressed. E-mail: clewis{at}adhb.govt.nz.

Accepted 16 March 2008


*   Abstract

The clinical impact of nocturnal desaturation on health-related quality of life (HRQL) and sleep in COPD has been little studied. We aimed to evaluate the prevalence and clinical impact of nocturnal desaturation in a typical outpatient population with COPD.

Between 2002 and 2005, consecutive patients with COPD attending outpatient services at the study centre underwent resting oximetry, if they were not on domiciliary oxygen therapy. If their resting saturations were less than 95%, overnight pulse oximetry was performed. Significant nocturnal desaturation was defined as spending more than 30% of at least one of two nights with a saturation of less than 90%. The Chronic Respiratory Questionnaire (CRQ) and SF-36 were used to assess HRQL, and the Pittsburgh Sleep Quality Index (PSQI), Epworth Sleepiness Score (ESS) and Functional Outcomes of Sleep (FOSQ) questionnaires were used to assess sleep quality and daytime function.

Of 1104 patients, 803 underwent resting oximetry and 79 had resting oxygen saturations of less than 95%. Of these, 59 agreed to undergo overnight oximetry (mean age 70.5 years, FEV1 37.2% predicted, resting pO2 on air 8.9 kPa). Significant nocturnal desaturation was seen in 29 (49.2%) of the 59 subjects. The prevalence of nocturnal desaturation in the whole clinic population could therefore be estimated at 4.8%. There were no significant differences in CRQ, SF-36, PSQI, ESS or FOSQ scores for desaturators when compared with non-desaturators.

Significant nocturnal desaturation was common in COPD patients with resting saturations of less than 95%, but was estimated to have a prevalence of less than 5% in the whole outpatient population. Nocturnal desaturation was not associated with impairment of HRQL, sleep quality or daytime function.








HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH REGISTER
Terms and conditions relating to subscriptions purchased online  ¦  Website terms and conditions  ¦  Privacy policy
Copyright © 2008 BMJ Publishing Group Ltd & British Thoracic Society